What is XBiotech Inc (XBIT) stock price today?

XBiotech Inc (XBIT) currently trades at $2.57 per share. The stock has a market capitalization of $77.44M and a P/E ratio of —x.

Is XBIT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, XBiotech Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is XBiotech Inc's revenue and earnings?

XBiotech Inc has trailing twelve-month (TTM) revenue of $300000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.49.

XBIT

XBiotech Inc

NASDAQ: XBIT · HEALTHCARE · BIOTECHNOLOGY

$2.57

+1.98% today

Updated 2026-04-30

Market cap

$77.44M

P/E ratio

—

P/S ratio

12.23x

EPS (TTM)

$-1.49

Dividend yield

—

52W range

$2 – $4

Volume

0.0M

Market cap

$77.44M

P/E ratio

—

P/S ratio

12.23x

EPS (TTM)

$-1.49

Dividend yield

—

52W range

$2 – $4

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$18.00

+600.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-22.99M

- Revenue declining -93.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$4.01M	$300000.00	$0.00	$0.00	$300000.00
Net income	$-32.90M	$-24.56M	$-38.53M	$-45.54M	$-26.89M
EPS	—	—	—	—	$-1.49
Free cash flow	$-15.41M	$-19.09M	$-32.27M	$-40.21M	$-22.99M
Profit margin	-820.45%	-8,185.67%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
XBIT	$77.44M	24	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

XBiotech Inc trades at $2.57. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $300000.00.

Frequently asked questions

What is XBiotech Inc's stock price?

XBiotech Inc (XBIT) trades at $2.57.

Is XBiotech Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of XBiotech Inc (XBIT)?

The analyst target price is $18.00, representing +600.4% upside from the current price of $2.57.

What is XBiotech Inc's revenue?

TTM revenue is $300000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12.23x

ROE-28.20%

Beta0.83

50D MA$2.37

200D MA$2.58

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

XBIT vs LLY →XBIT vs JNJ →XBIT vs ABBV →Stock screener →